Navigation Links
Suzanne M. Connolly, MD Named 2008-2009 President of Women's Dermatologic Society
Date:3/10/2008

SAN FRANCISCO, March 10 /PRNewswire/ -- The Women's Dermatologic Society (WDS) is pleased to announce the 2008-2009 presidency of Suzanne M. Connolly, MD, who took office at the recent WDS luncheon during the American Academy of Dermatology Annual Meeting in San Antonio, Texas. Dr. Connolly moved into the presidential role from this past year's position as WDS Vice-President and National Service Chair for the past three years. Mary P. Lupo, MD, served as the WDS 2007-08 President.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080310/AQM132-a)

(Logo: http://www.newscom.com/cgi-bin/prnh/20080310/AQM132LOGO-b)

Emblematic of her passion for working together to serve others, Dr. Connolly cited a favorite quote from Henry Ford as she assumed the presidency: "Coming together is a beginning; keeping together is progress; working together is success."

Under Dr. Connolly's exemplary leadership as Service Chair, the WDS conducted an award-winning community service outreach, Families Play Safe in the Sun, designed to educate, encourage and empower families to make sun safety a way of life. The 3-year, 15-city grassroots educational campaign was made possible by a generous grant from the 3M Foundation. Through this WDS Service project, nearly 400 WDS members across the nation have volunteered in communities where they work and live to educate the public about sun safety and provide free skin cancer screenings at large-scale events, reaching nearly 2 million people directly and creating 122 million media impressions. Thanks to a new grant from L'Oreal Foundation, the organization's efforts to educate the public about sun safety will continue through Play Safe in the Sun, geared for golf and tennis enthusiasts.

Dr. Connolly is an Associate Professor of Dermatology at the Mayo Clinic (Arizona). In addition to her various leadership roles in WDS, Dr. Connolly served as the 2006 President of the Pacific Dermatologic Association.

The Women's Dermatologic Society supports the careers and professional development of women dermatologists. The mission of the Women's Dermatologic Society is to help women in dermatology achieve their greatest personal and professional potential by striving to foster, promote, and support women's issues in dermatology; identify, train, and recognize women leaders in dermatology; provide a forum for developing relationships and the exchange of ideas and research relevant to women's issues; and promote the highest possible standards of ethics, research, patient care and education, as well as public education. WDS is comprised of more than 1,500 members nationally and internationally, representing all sub-specialties in dermatology and work in private practice, academics and research. Visit: http://www.womensderm.org


'/>"/>
SOURCE Women's Dermatologic Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. O.J. Brigance Named Honorary Chair of May 3 Race to Cure ALS, Confirms His Diagnosis by The Robert Packard Center for ALS Research at Johns Hopkins
2. Hostess(R) 100 Calorie Pack Cup Cakes Named A Most Memorable New Product of 2007
3. Anthem Blue Cross and Blue Shields Member Health Index Named BlueWorks(R) Award Winner
4. Ex-Cowboys Running Back Ron Springs Named Plaintiff in Constitutional Challenge to Texas Malpractice Award Cap
5. Venture Global Limited Introduces an Innovative Anti-Cellphone Radiation Sticker Named VEGO Power Blocker
6. Greg Cleary Named Vice President, Membership Administration for Kaiser Permanente
7. Smart Balance(R) Named MVP in Refrigerated & Frozen Foods Retailer Product Lineup
8. Nano Pet Products, LLC Named Exclusive Worldwide Licensee by Schoeller(R) Technologies AG for Pet Products to Develop the Most Technologically Advanced Pet Brands on the Market Today
9. Montefiore Lead Poisoning Prevention ProgramNamed One of Three State Regional Resource Centers
10. TriWest Named Top-Level Employer of Guard, Reserve Troops
11. Michael Beland Named as OrthoSynetics(TM) Corporate Controller
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: